[go: up one dir, main page]

NZ335078A - Composition, for the treatment of asthma, containing loratadine and a decongestant - Google Patents

Composition, for the treatment of asthma, containing loratadine and a decongestant

Info

Publication number
NZ335078A
NZ335078A NZ335078A NZ33507897A NZ335078A NZ 335078 A NZ335078 A NZ 335078A NZ 335078 A NZ335078 A NZ 335078A NZ 33507897 A NZ33507897 A NZ 33507897A NZ 335078 A NZ335078 A NZ 335078A
Authority
NZ
New Zealand
Prior art keywords
decongestant
asthma
treatment
composition
containing loratadine
Prior art date
Application number
NZ335078A
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NZ335078A publication Critical patent/NZ335078A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Compositions comprising loratadine and a decongestant are suitable for improving pulmonary function in a patient suffering from asthma.
NZ335078A 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant NZ335078A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (1)

Publication Number Publication Date
NZ335078A true NZ335078A (en) 2000-10-27

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ335078A NZ335078A (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (en)
JP (1) JP2000505104A (en)
KR (1) KR20000052922A (en)
CN (1) CN1235545A (en)
AR (1) AR008908A1 (en)
AU (1) AU731756B2 (en)
BR (1) BR9712705A (en)
CA (1) CA2268546A1 (en)
CO (1) CO4910128A1 (en)
CZ (1) CZ150999A3 (en)
HU (1) HUP9904075A3 (en)
ID (1) ID23431A (en)
IL (1) IL129662A0 (en)
NO (1) NO992062D0 (en)
NZ (1) NZ335078A (en)
PE (1) PE11399A1 (en)
PL (1) PL333056A1 (en)
SK (1) SK54599A3 (en)
TR (1) TR199901003T2 (en)
WO (1) WO1998018470A1 (en)
ZA (1) ZA979731B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307790A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
AR022378A1 (en) * 1998-09-10 2002-09-04 Schering Corp METHODS AND COMPOSITIONS TO TREAT SINUSITIS, MEDIUM OTITIS AND OTHER RELATED DISORDERS USING ANTIHISTAMINS
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
EP1154762B1 (en) * 1999-02-23 2003-11-05 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
KR100505899B1 (en) * 1999-02-23 2005-08-01 주식회사유한양행 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
SK287684B6 (en) * 1999-12-20 2011-06-06 Schering Corporation Sustained release solid oral pharmaceutical dosage composition
SK287105B6 (en) * 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
JP5592042B2 (en) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド Single dose antihistamine / decongestant formulation for the treatment of rhinitis
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
CN1518448A (en) * 2001-06-20 2004-08-04 ���鹫˾ Antihistamines for nasal congestion and congestion
NZ541960A (en) * 2005-06-17 2010-01-29 Aft Pharmaceuticals Ltd Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
RU2423979C2 (en) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Novel pharmaceutic composition and its application in method of treatment of patients with hyperaemia and edema of mucous membrane of upper airways
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
BRPI0712532A2 (en) * 2006-06-01 2013-04-02 Schering Plough Healthcare Prod Inc Phenylephrine formulations and pharmaceutical compositions for colonic absorption
KR101540191B1 (en) * 2014-02-24 2015-07-28 성균관대학교산학협력단 Composition comprising Loratadine for anti-inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
AR008908A1 (en) 2000-02-23
EP0941091A1 (en) 1999-09-15
KR20000052922A (en) 2000-08-25
ZA979731B (en) 1998-04-29
NO992062L (en) 1999-04-29
NO992062D0 (en) 1999-04-29
AU731756B2 (en) 2001-04-05
AU4995397A (en) 1998-05-22
JP2000505104A (en) 2000-04-25
CA2268546A1 (en) 1998-05-07
PE11399A1 (en) 1999-02-09
HUP9904075A3 (en) 2002-02-28
TR199901003T2 (en) 1999-07-21
CN1235545A (en) 1999-11-17
CO4910128A1 (en) 2000-04-24
PL333056A1 (en) 1999-11-08
IL129662A0 (en) 2000-02-29
SK54599A3 (en) 2000-08-14
CZ150999A3 (en) 1999-10-13
BR9712705A (en) 1999-10-26
WO1998018470A1 (en) 1998-05-07
HUP9904075A2 (en) 2000-05-28
ID23431A (en) 2000-04-20

Similar Documents

Publication Publication Date Title
NZ335078A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
IL116203A (en) Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron
EP0950665A4 (en) Modified physiologically active proteins and medicinal compositions containing the same
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
HUP9901874A3 (en) Human antibodies binding human tnfalfa, pharmaceutical compositions containing thereof and use thereof
CA2195093A1 (en) Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
GR990100140A (en) Novel compounds
CA2271944A1 (en) Formulation for electrically assisted delivery of lidocaine and epinephrine
EP0675120A3 (en) Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
CY2482B1 (en) Paroxetine in treatment of depression.
ZA973843B (en) Treatment of asthma with TNFR-lg.
HUP9903649A3 (en) Taxane derivatives, the preparation thereof and medical formulations containing them
BG104914A (en) Paroxetine maleate
MXPA01005600A (en) Small peptides and methods for treatment of asthma and inflammation.
GB9420616D0 (en) Method, compositions and use
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
MD980129A (en) Antiherpetic remedy
EP1000569A4 (en) Chair and its rotating table
HK1018941A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
EP0824101B1 (en) Carbosilane dendrimers containing Si-O-metal bonds, process for their preparation and their use
AU5257198A (en) Compositions and methods for treating type ii diabetes involving hnf-4
HUP0104262A3 (en) Pharmaceutical composition containing 2,4-dioxothiazolidine-derivative and process for its use
AU2973997A (en) Use of substituted azaspirane in the treatment of asthma
AU3423397A (en) Therapeutic methods and compositions for use therein